Diagnostic accuracy and clinical usefulness of erythrocyte creatine content to predict the improvement of anaemia in patients receiving maintenance haemodialysis

BACKGROUND: The improvement of anaemia over time by erythropoiesis stimulating agent (ESA) is associated with better survival in haemodialysis patients. We previously reported that erythrocyte creatine content, a marker of erythropoietic capacity, was a reliable marker to estimate the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Ohki, Nakamura, Seishi, Sugiura, Tetsuro, Hasegawa, Shun, Tsuka, Yoshiaki, Takahashi, Nobuyuki, Kikuchi, Sanae, Matsumura, Koichiro, Okumiya, Toshika, Baden, Masato, Shiojima, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808937/
https://www.ncbi.nlm.nih.gov/pubmed/36597041
http://dx.doi.org/10.1186/s12882-022-03055-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808937/
https://www.ncbi.nlm.nih.gov/pubmed/36597041
http://dx.doi.org/10.1186/s12882-022-03055-4

Ejemplares similares